There is no relationship between SOD2 Val-16Ala polymorphism and breast cancer risk or survival.
Molecular and clinical oncology 2017 Oct 7 (4): 579-590.
Wang Chengdi, Liu Yang, Zhou Jian, Ye Lei, Chen Nan, Zhu Min, Ji Yul
No association between SOD2 Val16Ala polymorphism and breast cancer susceptibility: a meta-analysis based on 9,710 cases and 11,041 controls.
Breast cancer research and treatment 2010 Jul 122 (2): 509-14.
Ma Xiangyu, Chen Chunhai, Xiong Hongyan, Fan Jin, Li Yafei, Lin Hui, Xu Rufu, Huang Guorong, Xu B